Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NeoRecormon for Anemia Correction in ESRD Patients
NCT00413101Phase 4Completed
- Sponsor
- Roche
- Modality
- Erythropoietins, Colony Stimulating Factors
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of epoetin beta in anemia, sponsored by Roche. Primary endpoints: Hemoglobin, Blood Pressure and 2 more. Status: completed.
02
Drugs
epoetin beta
03
Conditions
anemia
Beyond the preview
Go deeper on NCT00413101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00413101.